Your PROSCA case challenge
You edit a major uro-oncology journal and feel very proud that, last month, your journal published a European randomized trial on the treatment of locally advanced prostate cancer that seems to answer some of our most fundamental questions.
This morning, however, you have received an anonymous e-mail from a physician informing you that the randomized trial had never taken place and the data is largely fabricated. What do you do next?